BREAST CANCER RESEARCH AND TREATMENT

BREAST CANCER RESEARCH AND TREATMENT

BREAST CANCER RES TR
影响因子:3
是否综述期刊:
是否预警:不在预警名单内
是否OA:
出版国家/地区:UNITED STATES
出版社:Springer US
发刊时间:1981
发刊频率:Semimonthly
收录数据库:SCIE/Scopus收录
ISSN:0167-6806

期刊介绍

Breast Cancer Research and Treatment provides the surgeon, radiotherapist, medical oncologist, endocrinologist, epidemiologist, immunologist or cell biologist investigating problems in breast cancer a single forum for communication. The journal creates a "market place" for breast cancer topics which cuts across all the usual lines of disciplines, providing a site for presenting pertinent investigations, and for discussing critical questions relevant to the entire field. It seeks to develop a new focus and new perspectives for all those concerned with breast cancer.
乳腺癌研究和治疗提供了外科医生,放射治疗师,医学肿瘤学家,内分泌学家,流行病学家,免疫学家或细胞生物学家调查乳腺癌问题的一个单一的论坛交流。该杂志为乳腺癌主题创建了一个“市场”,该主题跨越了所有常规学科,为展示相关调查和讨论与整个领域相关的关键问题提供了一个网站。它寻求为所有与乳腺癌有关的人开发新的重点和新的观点。
年发文量 350
国人发稿量 44.03
国人发文占比 0.13%
自引率 -
平均录取率0
平均审稿周期 平均1月
版面费 US$3790
偏重研究方向 医学-肿瘤学
期刊官网 https://www.springer.com/10549
投稿链接 https://www.editorialmanager.com/brea

期刊高被引文献

Yoga has a solid effect on cancer-related fatigue in patients with breast cancer: a meta-analysis
来源期刊:Breast Cancer Research and TreatmentDOI:10.1007/s10549-019-05278-w
A randomized, double-blind, window of opportunity trial evaluating the effects of chloroquine in breast cancer patients
来源期刊:Breast Cancer Research and TreatmentDOI:10.1007/s10549-019-05381-y
Prognostic and clinicopathological value of PD-L1 expression in primary breast cancer: a meta-analysis
来源期刊:Breast Cancer Research and TreatmentDOI:10.1007/s10549-019-05371-0
SNAIL is induced by tamoxifen and leads to growth inhibition in invasive lobular breast carcinoma
来源期刊:Breast Cancer Research and TreatmentDOI:10.1007/s10549-019-05161-8
Palbociclib and endocrine therapy in heavily pretreated hormone receptor-positive HER2-negative advanced breast cancer: the UK Compassionate Access Programme experience
来源期刊:Breast Cancer Research and TreatmentDOI:10.1007/s10549-019-05134-x
Improved survival of older patients with advanced breast cancer due to an increase in systemic treatments: a population-based study
来源期刊:Breast Cancer Research and TreatmentDOI:10.1007/s10549-019-05356-z
Adjuvant chemotherapy in lobular carcinoma of the breast: a clinicopathological score identifies high-risk patient with survival benefit
来源期刊:Breast Cancer Research and TreatmentDOI:10.1007/s10549-019-05160-9
The prognostic significance of wild-type isocitrate dehydrogenase 2 (IDH2) in breast cancer
来源期刊:Breast Cancer Research and TreatmentDOI:10.1007/s10549-019-05459-7
Vaginal CO2 laser for the treatment of vulvovaginal atrophy in women with breast cancer: LAAVA pilot study
来源期刊:Breast Cancer Research and TreatmentDOI:10.1007/s10549-019-05384-9
Marital status is an independent prognostic factor in inflammatory breast cancer patients: an analysis of the surveillance, epidemiology, and end results database
来源期刊:Breast Cancer Research and TreatmentDOI:10.1007/s10549-019-05385-8
Multi-targeted kinase inhibition alleviates mTOR inhibitor resistance in triple-negative breast cancer
来源期刊:Breast Cancer Research and TreatmentDOI:10.1007/s10549-019-05380-z
T-bet+ lymphocytes infiltration as an independent better prognostic indicator for triple-negative breast cancer
来源期刊:Breast Cancer Research and TreatmentDOI:10.1007/s10549-019-05256-2
Quality of life in pre- and postmenopausal patients with early breast cancer: a comprehensive analysis from the prospective MaLife project
来源期刊:Breast Cancer Research and TreatmentDOI:10.1007/s10549-019-05197-w
Chemotherapy-induced peripheral neuropathy (CIPN) in breast cancer survivors: a comparison of patient-reported outcomes and quantitative sensory testing
来源期刊:Breast Cancer Research and TreatmentDOI:10.1007/s10549-019-05416-4
GEC-ESTRO APBI classification as a decision-making tool for the management of 2nd ipsilateral breast tumor event
来源期刊:Breast Cancer Research and TreatmentDOI:10.1007/s10549-019-05221-z
Explaining variation in quality of breast cancer care and its impact: a nationwide population-based study from Slovenia
来源期刊:Breast Cancer Research and TreatmentDOI:10.1007/s10549-019-05186-z
Anti-tumor and anti-metastasis efficacy of E6201, a MEK1 inhibitor, in preclinical models of triple-negative breast cancer
来源期刊:Breast Cancer Research and TreatmentDOI:10.1007/s10549-019-05166-3
The prognostic significance of preoperative tumor marker (CEA, CA15-3) elevation in breast cancer patients: data from the Korean Breast Cancer Society Registry
来源期刊:Breast Cancer Research and TreatmentDOI:10.1007/s10549-019-05357-y
Propagation of functional estrogen receptor positive normal human breast cells in 3D cultures
来源期刊:Breast Cancer Research and TreatmentDOI:10.1007/s10549-019-05229-5
Assessing the effectiveness of the National Comprehensive Cancer Network genetic testing guidelines in identifying African American breast cancer patients with deleterious genetic mutations
来源期刊:Breast Cancer Research and TreatmentDOI:10.1007/s10549-019-05359-w
Transforming growth factor beta receptor II (TGFBR2) promoter region polymorphism in Brazilian breast cancer patients: association with susceptibility, clinicopathological features, and interaction with TGFB1 haplotypes
来源期刊:Breast Cancer Research and TreatmentDOI:10.1007/s10549-019-05370-1
Bimodal age distribution at diagnosis in breast cancer persists across molecular and genomic classifications
来源期刊:Breast Cancer Research and TreatmentDOI:10.1007/s10549-019-05442-2
Incidental breast carcinoma: incidence, management, and outcomes in 4804 bilateral reduction mammoplasties
来源期刊:Breast Cancer Research and TreatmentDOI:10.1007/s10549-019-05335-4
Mode of detection and breast cancer mortality by follow-up time and tumor characteristics among screened women in Cancer Prevention Study-II
来源期刊:Breast Cancer Research and TreatmentDOI:10.1007/s10549-019-05322-9
Prophylactic acupuncture treatment during chemotherapy with breast cancer: a randomized pragmatic trial with a retrospective nested qualitative study
来源期刊:Breast Cancer Research and TreatmentDOI:10.1007/s10549-019-05431-5
A generalizable relationship between mortality and time-to-death among breast cancer patients can be explained by tumour dormancy
来源期刊:Breast Cancer Research and TreatmentDOI:10.1007/s10549-019-05334-5
Effects of tea consumption and the interactions with lipids on breast cancer survival
来源期刊:Breast Cancer Research and TreatmentDOI:10.1007/s10549-019-05253-5
Clinico-pathologic and mammographic characteristics of inflammatory and non-inflammatory breast cancer at six centers in North Africa
来源期刊:Breast Cancer Research and TreatmentDOI:10.1007/s10549-019-05237-5
Gene expression analysis to detect disseminated tumor cells in the bone marrow of triple-negative breast cancer patients predicts metastatic relapse
来源期刊:Breast Cancer Research and TreatmentDOI:10.1007/s10549-019-05405-7
Effects of cyclic adjustment training delivered via a mobile device on psychological resilience, depression, and anxiety in Chinese post-surgical breast cancer patients
来源期刊:Breast Cancer Research and TreatmentDOI:10.1007/s10549-019-05368-9
Time-to-surgery and overall survival after breast cancer diagnosis in a universal health system
来源期刊:Breast Cancer Research and TreatmentDOI:10.1007/s10549-019-05404-8
Racial differences in employment and cost-management behaviors in patients with metastatic breast cancer
来源期刊:Breast Cancer Research and TreatmentDOI:10.1007/s10549-019-05449-9
Oophorectomy and risk of contralateral breast cancer among BRCA1 and BRCA2 mutation carriers
来源期刊:Breast Cancer Research and TreatmentDOI:10.1007/s10549-019-05162-7
A multicentre, randomized pilot trial comparing vascular access strategies for early stage breast cancer patients receiving non-trastuzumab containing chemotherapy
来源期刊:Breast Cancer Research and TreatmentDOI:10.1007/s10549-019-05388-5
Optimal treatment of breast cancer in women older than 75 years: a Korea Breast Cancer Registry analysis
来源期刊:Breast Cancer Research and TreatmentDOI:10.1007/s10549-019-05426-2
Weekly carboplatin plus neoadjuvant anthracycline-taxane-based regimen in early triple-negative breast cancer: a prospective phase II trial by the Breast Cancer Task Force of the Belgian Society of Medical Oncology (BSMO)
来源期刊:Breast Cancer Research and TreatmentDOI:10.1007/s10549-019-05259-z
Efficacy of intraoperative specimen radiography as margin assessment tool in breast conserving surgery
来源期刊:Breast Cancer Research and TreatmentDOI:10.1007/s10549-019-05476-6
Clinical relevance of H-RAS, K-RAS, and N-RAS mRNA expression in primary breast cancer patients
来源期刊:Breast Cancer Research and TreatmentDOI:10.1007/s10549-019-05474-8
Assessing the additional surgical risk of contralateral prophylactic mastectomy and immediate breast implant reconstruction
来源期刊:Breast Cancer Research and TreatmentDOI:10.1007/s10549-019-05460-0
The impact of hospital volume on patient safety indicators following post-mastectomy breast reconstruction in the US
来源期刊:Breast Cancer Research and TreatmentDOI:10.1007/s10549-019-05361-2
Breast density measured volumetrically in a clinical environment: cross-sectional study with photon counting technology
来源期刊:Breast Cancer Research and TreatmentDOI:10.1007/s10549-019-05502-7
Molecular determinants of drug response in TNBC cell lines
来源期刊:Breast Cancer Research and TreatmentDOI:10.1007/s10549-019-05473-9
Correction to: The 3′UTR of the pseudogene CYP4Z2P promotes tumor angiogenesis in breast cancer by acting as a ceRNA for CYP4Z1
来源期刊:Breast Cancer Research and TreatmentDOI:10.1007/s10549-019-05478-4
The use of contralateral prophylactic mastectomy among elderly patients in the United States
来源期刊:Breast Cancer Research and TreatmentDOI:10.1007/s10549-019-05288-8
A phase Ib, open-label, dose-escalation study of the safety and pharmacology of taselisib (GDC-0032) in combination with either docetaxel or paclitaxel in patients with HER2-negative, locally advanced, or metastatic breast cancer
来源期刊:Breast Cancer Research and TreatmentDOI:10.1007/s10549-019-05360-3
Improving surgical efficiency of immediate implant-based breast reconstruction following mastectomy
来源期刊:Breast Cancer Research and TreatmentDOI:10.1007/s10549-019-05175-2
Letter regarding Sopik V et al. entitled “Impact of microinvasion on breast cancer mortality in women with ductal carcinoma in situ”
来源期刊:Breast Cancer Research and TreatmentDOI:10.1007/s10549-019-05389-4
Re: Association of depression and anxiety disorder with the risk of mortality in breast cancer
来源期刊:Breast Cancer Research and TreatmentDOI:10.1007/s10549-019-05510-7
Proper treatment of breast angiosarcoma-mastectomy or breast conserving surgery?
来源期刊:Breast Cancer Research and TreatmentDOI:10.1007/s10549-019-05509-0
Precision medicine: PI3K targeting in advanced breast cancer
来源期刊:Breast Cancer Research and TreatmentDOI:10.1007/s10549-019-05409-3

质量指标占比

研究类文章占比 OA被引用占比 撤稿占比 出版后修正文章占比
92.86%39.38%--

相关指数

影响因子
影响因子
年发文量
自引率
Cite Score

预警情况

查看说明
时间 预警情况
2025年03月发布的2025版不在预警名单中
2024年02月发布的2024版不在预警名单中
2023年01月发布的2023版不在预警名单中
2021年12月发布的2021版不在预警名单中
2020年12月发布的2020版不在预警名单中
*来源:中科院《 国际期刊预警名单》

JCR分区

WOS分区等级:Q2区
版本 按学科 分区
WOS期刊SCI分区
WOS期刊SCI分区
WOS期刊SCI分区是指SCI官方(Web of Science)为每个学科内的期刊按照IF数值排 序,将期刊按照四等分的方法划分的Q1-Q4等级,Q1代表质量最高,即常说的1区期刊。
(2024-2025年最新版)
ONCOLOGY
Q2

中科院分区

查看说明
版本 大类学科 小类学科 Top期刊 综述期刊
2025年3月最新升级版
医学3区
ONCOLOGY 肿瘤学
3区
2023年12月升级版
医学3区
ONCOLOGY 肿瘤学
3区
2022年12月旧的升级版
医学2区
ONCOLOGY 肿瘤学
3区